KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan Jul 02, 2024 7:00am EDT
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion Jun 05, 2024 9:00am EDT
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic Jun 04, 2024 4:03pm EDT
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic May 14, 2024 4:05pm EDT
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth May 01, 2024 4:05pm EDT
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 Apr 17, 2024 7:00am EDT
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference Mar 18, 2024 5:24pm EDT
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance Mar 13, 2024 4:05pm EDT
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic Mar 11, 2024 4:05pm EDT
